Xenon Pharmaceuticals Inc
XENE · NASDAQ
Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.
ESG Scores
Overall ESG6.8
Environmental6.4
Social3.9
Governance6.5
Gender Diversity
Female Directors0.25%
Female Executives0.23529411764705882%
CEO GenderMale